Stocks and InvestingStocks and Investing
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022

Ed Arce Maintained (TERN) at Hold with Increased Target to $7 on, Dec 29th, 2022


Published on 2024-10-28 00:42:18 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Terns Pharmaceuticals, Inc." (TERN) at Hold with Increased Target from $6 to $7 on, Dec 29th, 2022.

Ed has made no other calls on TERN in the last 4 months.



There is 1 other peer that has a rating on TERN. Out of the 1 peers that are also analyzing TERN, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022